Wealthcare Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-152
Closed -$38K 108
2021
Q1
$38K Buy
+152
New +$36.3K ﹤0.01% 163
2020
Q2
Sell
-15
Closed -$3K 64
2020
Q1
$3K Sell
15
-30
-67% -$6.55K ﹤0.01% 195
2019
Q4
$11K Buy
+45
New +$9.92K ﹤0.01% 175
2018
Q1
Sell
-16
Closed -$3K 200
2017
Q4
$3K Buy
+16
New +$2.83K ﹤0.01% 168
2015
Q2
Sell
-460
Closed -$74K 399
2015
Q1
$74K Buy
+460
New +$72.4K 0.01% 187
2014
Q1
Sell
-25
Closed -$3K 163
2013
Q4
$3K Hold
25
﹤0.01% 99
2013
Q3
$3K Hold
25
﹤0.01% 98
2013
Q2
$2K Buy
+25
New +$2.59K ﹤0.01% 107

Other funds holding AMGN

Wealthcare Capital Management's AMGN Position: Q2 2021 in Review

Wealthcare Capital Management sold out of Amgen (AMGN) in Q2 2021, closing a stake of 152 shares — an estimated $38K sold.

Wealthcare Capital Management first reported a position in AMGN in Q2 2013 and held it in 8 quarters. The position peaked at $74K in Q1 2015. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Wealthcare Capital Management reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Capital Management sold 152 Amgen shares in Q2 2021, an estimated $38K.
  • Wealthcare Capital Management first reported a position in Amgen in Q2 2013 and held it in 8 quarters.
  • Wealthcare Capital Management's Amgen position peaked at $74K in Q1 2015.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Wealthcare Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.